{"id":5749,"date":"2012-11-20T20:46:00","date_gmt":"2012-11-20T20:46:00","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/ingenuity-variant-analysis-sees-exponential-customer-adoption\/"},"modified":"2012-11-20T20:46:00","modified_gmt":"2012-11-20T20:46:00","slug":"ingenuity-variant-analysis-sees-exponential-customer-adoption","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/human-genetics\/ingenuity-variant-analysis-sees-exponential-customer-adoption\/","title":{"rendered":"Ingenuity Variant Analysis Sees Exponential Customer Adoption"},"content":{"rendered":"<p><p>          More than 1,100 users from over 500          institutions        <\/p>\n<p>          REDWOOD CITY, Calif. - Ingenuity Systems, a leading          provider of biomedical information and analysis          solutions, today highlighted strong adoption of its          Variant Analysis platform at the American Society of          Human Genetics Annual Meeting in San Francisco. Variant          Analysis, a web-based analysis application, answers a          critical need for researchers trying to rapidly identify          relevant casual variants in human diseases from          re-sequencing data.        <\/p>\n<p>          Over the past 6 months the number of users and samples          uploaded into Ingenuity Variant Analysis has grown 250%          month-over-month and today 1,100 users are actively          working on whole genome and exome projects ranging from          individual genomes to thousands of genomes. The users          represent over 500 leading institutions and drug          discovery companies studying all stages of basic,          translational and clinical research.        <\/p>\n<p>          \"All of us need help interpreting DNA sequence variation          in the context of the world's literature and rapidly          evolving databases,\" said David M. Margulies, MD,          Executive Director, Gene Partnership, Children's Hospital          Boston and member of Faculties of Genetics,          Bioinformatics, and Developmental Medicine, Harvard          Medical School. \"Ingenuity's rigorous methods for          curating variant information and its deep capabilities in          relating sequence and expression data to underlying          pathways are invaluable to us as we seek to understand          the contribution of sequence variation to disease in both          clinical and discovery scenarios.\"        <\/p>\n<p>          \"The interpretation of human genomes for medical and          biological relevance is a major challenge. Variant          Analysis has proven to be a helpful tool to contribute to          the interpretation of our exome sequencing-based          studies,\" stated Estelle Chanudet-van den Brink, PhD,          Senior Research Associate, GOSgene, University College of          London. \"We tested it in the context of 9 different rare          genetic conditions (73 samples total), including various          modes of inheritance. We found the process intuitive and          the analytic parameters pragmatically fitted to the          diversity of our data. The access to rich biological          content, that leverages information on pathways and          disease models, was particularly useful to support the          prioritization of variants for further analyses. We are          now extending the use of Variant Analysis to additional          cohorts of patients (250 samples).\"        <\/p>\n<p>          \"Increasing access to the unique content and intuitive          graphical user interface in Variant Analysis allowed us          to quickly identify variants of interest in our          sequencing data on muscular dystrophy,\" said Susan          Dorsey, PhD, RN, FAAN, Associate Dean for Research,          University of Maryland. \"In a matter of hours, we were          able to quickly learn how to use the tool and obtain          preliminary results. I anticipate that we will be working          with the company and its tools for years to come.\"        <\/p>\n<p>          Further, at ASHG this week in San Francisco, attendees          will have will have the opportunity to demo Variant          Analysis in the Ingenuity booth #1101 or through its          integration into third-party applications such as Ion          Torrent's Ion Reporter and Illumina's BaseSpace.        <\/p>\n<p>          About Ingenuity Systems          Ingenuity Systems is a leading provider of biomedical          information and analysis solutions for the exploration,          interpretation and analysis of complex biological systems          in life science research and molecular diagnostics.          Today, Ingenuity's solutions are used by tens of          thousands of researchers and clinicians at hundreds of          leading pharmaceutical, biotechnology, academic,          diagnostic and clinical institutions worldwide.        <\/p>\n<p>          SOURCE          Ingenuity Systems        <\/p>\n<p>          CONTACT: Dione Bailey, Director of Marketing for          Ingenuity Systems, +1-650-381-5025, <a href=\"mailto:dbailey@ingenuity.com\">dbailey@ingenuity.com<\/a>        <\/p>\n<\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.thomasnet.com\/companystory\/Ingenuity-Variant-Analysis-Sees-Exponential-Customer-Adoption-624512\" title=\"Ingenuity Variant Analysis Sees Exponential Customer Adoption\">Ingenuity Variant Analysis Sees Exponential Customer Adoption<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> More than 1,100 users from over 500 institutions REDWOOD CITY, Calif. - Ingenuity Systems, a leading provider of biomedical information and analysis solutions, today highlighted strong adoption of its Variant Analysis platform at the American Society of Human Genetics Annual Meeting in San Francisco. Variant Analysis, a web-based analysis application, answers a critical need for researchers trying to rapidly identify relevant casual variants in human diseases from re-sequencing data <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/human-genetics\/ingenuity-variant-analysis-sees-exponential-customer-adoption\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-5749","post","type-post","status-publish","format-standard","hentry","category-human-genetics"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/5749"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=5749"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/5749\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=5749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=5749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=5749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}